188 related articles for article (PubMed ID: 35455984)
1. B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet's Disease.
Maghrebi O; Belghith M; Jeridi C; Rachdi A; Fatnassi FN; Saied Z; Belal S; Ben Sassi S; Barbouche MR
Cells; 2022 Apr; 11(8):. PubMed ID: 35455984
[TBL] [Abstract][Full Text] [Related]
2. Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.
Belghith M; Maghrebi O; Ben Laamari R; Hanachi M; Hrir S; Saied Z; Belal S; Driss A; Ben Sassi S; Boussoffara T; Barbouche MR
Cytokine; 2024 Jul; 179():156617. PubMed ID: 38631183
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
[TBL] [Abstract][Full Text] [Related]
4. Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease.
Bahrini K; Belghith M; Maghrebi O; Bekir J; Kchaou M; Jeridi C; Amouri R; Hentati F; Belal S; Ben Sassi S; Barbouche MR
Cytokine; 2020 Mar; 130():155054. PubMed ID: 32151963
[TBL] [Abstract][Full Text] [Related]
5. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
6. Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
Belghith M; Maghrebi O; Cherif A; Bahrini K; Saied Z; Belal S; Sassi SB; Barbouche MR; Kchaou M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956031
[TBL] [Abstract][Full Text] [Related]
7. BAFF is up-regulated in central nervous system of neuro-Behçet's disease.
Hamzaoui K; Houman H; Hentati F; Hamzaoui A
J Neuroimmunol; 2008 Aug; 200(1-2):111-4. PubMed ID: 18625522
[TBL] [Abstract][Full Text] [Related]
8. Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Romme Christensen J; Börnsen L; Hesse D; Krakauer M; Sørensen PS; Søndergaard HB; Sellebjerg F
J Neuroinflammation; 2012 Sep; 9():215. PubMed ID: 22978757
[TBL] [Abstract][Full Text] [Related]
9. The Cerebrospinal Fluid Presentations of Neuro-Bechet Disease, a Way to Know the Etiopathogenesis and Improve Armamentarium.
Banerjee S; Hamzoui K; Safari A; Borhani-Haghighi A
Iran J Immunol; 2021 Sep; 18(3):170-178. PubMed ID: 34596581
[TBL] [Abstract][Full Text] [Related]
10. Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Behçet Disease.
Maghrebi O; Hanachi M; Bahrini K; Kchaou M; Jeridi C; Belal S; Ben Sassi S; Barbouche MR; Souiai O; Belghith M
Front Genet; 2021; 12():638236. PubMed ID: 33719347
[TBL] [Abstract][Full Text] [Related]
11. [Recent aspects of Neuro-Behcet's disease].
Hirohata S
Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
[TBL] [Abstract][Full Text] [Related]
12. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
13. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease.
Hamzaoui K; Borhani Haghighi A; Ghorbel IB; Houman H
J Neuroimmunol; 2011 Apr; 233(1-2):249-53. PubMed ID: 21367463
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):405-13. PubMed ID: 21935641
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
16. GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease.
Nakano H; Kirino Y; Takeno M; Higashitani K; Nagai H; Yoshimi R; Yamaguchi Y; Kato I; Aoki I; Nakajima H
Arthritis Res Ther; 2018 Jun; 20(1):124. PubMed ID: 29895319
[TBL] [Abstract][Full Text] [Related]
17. Primary Headache in Behçet's and Neuro-Behçet's Disease.
Beton OE; Yucesan C
Neurol India; 2022; 70(1):254-257. PubMed ID: 35263891
[TBL] [Abstract][Full Text] [Related]
18. Nutritional Status in patients with Neuro-Behçet's disease.
Erdoğan S; Sorgun MH; Kuzu Mumcu M; Kural MA; Rzayev S; Yücesan C
Turk J Med Sci; 2021 Aug; 51(4):1682-1688. PubMed ID: 33600096
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome.
Hamzaoui K; Borhani-Haghighi A; Dhifallah IB; Hamzaoui A
J Neuroimmunol; 2022 Apr; 365():577820. PubMed ID: 35123164
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
